Skip to main content

Rene Letourneau

Rene is a former Editor for Healthcare Finance News.

By Rene Letourneau | 04:41 pm | October 03, 2012
The global market for infertility drugs and devices will reach nearly $4.8 billion in 2017, said a recent report from Transparency Market Research.
By Rene Letourneau | 01:51 pm | October 02, 2012
The Massachusetts Medical Society released Tuesday the results of its annual study of the state's physician workforce. Physician shortages, difficulty with recruiting and dissatisfaction with the working environment ranked among the chief concerns identified in the study.
By Rene Letourneau | 11:52 am | October 01, 2012
A recent report from J.D. Power and Associates indicates that customers are becoming less satisfied with purchasing prescriptions through mail-order pharmacies as compared to brick and mortar locations, especially in the area of cost.
By Rene Letourneau | 09:39 am | September 28, 2012
For the first time in decades, sales of vaccines declined in 2011, due in large part to a weak flu season, said a recent report from healthcare market research publisher Kalorama Information.
By Rene Letourneau | 08:42 am | September 27, 2012
The average salary for a certified medical coder in 2012 is $47,796, up nearly $900 from 2011, according to a recent survey from AAPC, a member association focused on the training and credentialing of medical staff.
By Rene Letourneau | 01:42 pm | September 25, 2012
Global competition and the impending medical device tax, set to begin Jan. 1, 2013, are creating challenges for the U.S. biomedical device industry, according to a new study by tax advisory firm WTP Advisors.
By Rene Letourneau | 09:14 am | September 24, 2012
The Parkinson's Disease Foundation (PDF) last week awarded $1.35 million in research grants for 13 novel projects designed to find the cause(s) of and a cure for Parkinson's disease.
By Rene Letourneau | 02:46 pm | September 20, 2012
Ten major biopharmaceutical companies announced Wednesday that they have joined forces to form a nonprofit organization called TransCelerate BioPharma Inc., to accelerate the development of new medicines.
By Rene Letourneau | 12:13 pm | September 20, 2012
The global insulin market is expected to reach $32 billion by 2018, increasing at a compound annual growth rate of 12 percent from its 2011 market value of $12.4 billion, according to a new report from Transparency Market Research.
By Rene Letourneau | 10:22 am | September 19, 2012
Healthcare employees will see a modest base salary bump in 2012, according to the recent Healthcare Compensation Study from management consulting firm Hay Group.